Bank of America downgrades from buy to neutral and reduces price to $12/share.Give me a break!I listened to the investor presentation 2x last week and they have 3 drugs they are testing that could each be blockbusters.Granted that the results are early,but this is a proven team that can bring drugs to market. In addition for the first time the CEO stated that their rThrombin drug will eventually take the company to profitability.